10 0 (0%) | 01-30 15:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 12.4 | 1-year : | 12.84 |
Resists | First : | 10.61 | Second : | 11 |
Pivot price | 10 | |||
Supports | First : | 10 | Second : | 8.31 |
MAs | MA(5) : | 10 | MA(20) : | 10 |
MA(100) : | 10 | MA(250) : | 9.12 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 0 | D(3) : | 0 |
RSI | RSI(14): 84.3 | |||
52-week | High : | 11.89 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ VHAQ ] has closed Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 11.03 - 11.08 | 11.08 - 11.12 |
Low: | 9.86 - 9.93 | 9.93 - 9.98 |
Close: | 9.9 - 10.01 | 10.01 - 10.09 |
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia.
Mon, 22 Jul 2024
Clearday and Viveon Healthcare Acquisition To Merge - citybiz
Tue, 13 Sep 2022
Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP Treatments - PR Newswire
Fri, 29 Apr 2022
Viveon Health Acquisition Corp. Received Audit Opinion with Going Concern Explanation - Business Wire
Tue, 08 Feb 2022
Suneva Surpasses 1 Million Syringes of Bellafill® Distributed Since the Biostimulator's Inception - PR Newswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
AMEX
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 7 (M) |
Shares Float | 0 (M) |
Held by Insiders | 88.4 (%) |
Held by Institutions | 1 (%) |
Shares Short | 1 (K) |
Shares Short P.Month | 2 (K) |
EPS | -0.04 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -2.32 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -3.3 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -1 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -250 |
PEG Ratio | 0 |
Price to Book value | -4.32 |
Price to Sales | 0 |
Price to Cash Flow | -44.64 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |